For semaglutide 2.4mg (Wegovy), the SmPC and European regulatory assessment report cholelithiasis in approximately 1.6% of participants versus 0.7% in the control group, and cholecystitis in approximately 0.6% versus 0.2%
For Hashimotos, three peptides are particularly relevant: bpc-157 , KPV, and thymosin alpha-1
Alexis Cutchins: No, that's fascinating
MercadalLCoudertMVassaultAPieroniLDebureAOuzialaMet alL-carnitine treatment in incident hemodialysis patients: The multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial
BPC-157 and TB-500 are widely known for their ability to accelerate recovery from injuries and improve tissue regeneration, while Thymosin Alpha-1 strengthens immune defenses to help the body stay resilient against illness
Nuclear Medicine: Official Publication Soc